CR11_RANGI
ID CR11_RANGI Reviewed; 25 AA.
AC P62569; P56226;
DT 19-JUL-2004, integrated into UniProtKB/Swiss-Prot.
DT 19-JUL-2004, sequence version 1.
DT 25-MAY-2022, entry version 32.
DE RecName: Full=Caerin-1.1;
DE Contains:
DE RecName: Full=Caerin-1.1.1;
DE Contains:
DE RecName: Full=Caerin-1.1.3;
DE Contains:
DE RecName: Full=Caerin-1.1.5;
DE Contains:
DE RecName: Full=Caerin-1.1.6;
DE Contains:
DE RecName: Full=Caerin-1.1.7;
DE Contains:
DE RecName: Full=Caerin-1.1.8;
OS Ranoidea gilleni (Centralian tree frog) (Litoria gilleni).
OC Eukaryota; Metazoa; Chordata; Craniata; Vertebrata; Euteleostomi; Amphibia;
OC Batrachia; Anura; Neobatrachia; Hyloidea; Hylidae; Pelodryadinae; Ranoidea.
OX NCBI_TaxID=39405;
RN [1]
RP PROTEIN SEQUENCE, AMIDATION AT LEU-25, AND MASS SPECTROMETRY.
RC TISSUE=Parotoid gland;
RA Waugh R.J., Stone D.J.M., Bowie J.H., Wallace J.C., Tyler M.J.;
RT "Peptides from Australian frogs. The structures of the caerins and
RT caeridins from Litoria gilleni.";
RL J. Chem. Res. 139:937-961(1993).
CC -!- FUNCTION: Antibacterial and antiviral peptides that adopt an alpha
CC helical conformation which can disrupt bacterial membranes. Each caerin
CC displays a different antimicrobial specificity.
CC -!- SUBCELLULAR LOCATION: Secreted.
CC -!- TISSUE SPECIFICITY: Expressed by the skin parotoid and/or rostral
CC glands.
CC -!- DOMAIN: Contains two amphipathic alpha helix regions separated by a
CC region of less-defined helicity and greater flexibility.
CC -!- PTM: The major product is Caerin-1.1; in addition, different peptides
CC are produced that are missing some amino acid residues at the N-
CC terminus or C-terminus. Caerin-1.1.1 is inactive.
CC -!- MASS SPECTROMETRY: [Caerin-1.1]: Mass=2582; Method=FAB;
CC Evidence={ECO:0000269|Ref.1};
CC -!- MASS SPECTROMETRY: [Caerin-1.1.1]: Mass=2412; Method=FAB;
CC Evidence={ECO:0000269|Ref.1};
CC -!- MASS SPECTROMETRY: [Caerin-1.1.3]: Mass=1421; Method=FAB;
CC Evidence={ECO:0000269|Ref.1};
CC -!- MASS SPECTROMETRY: [Caerin-1.1.5]: Mass=1626; Method=FAB;
CC Evidence={ECO:0000269|Ref.1};
CC -!- MASS SPECTROMETRY: [Caerin-1.1.6]: Mass=1489; Method=FAB;
CC Evidence={ECO:0000269|Ref.1};
CC -!- MASS SPECTROMETRY: [Caerin-1.1.7]: Mass=1180; Method=FAB;
CC Evidence={ECO:0000269|Ref.1};
CC -!- MASS SPECTROMETRY: [Caerin-1.1.8]: Mass=915; Method=FAB;
CC Evidence={ECO:0000269|Ref.1};
CC -!- SIMILARITY: Belongs to the frog skin active peptide (FSAP) family.
CC Caerin subfamily. {ECO:0000305}.
CC ---------------------------------------------------------------------------
CC Copyrighted by the UniProt Consortium, see https://www.uniprot.org/terms
CC Distributed under the Creative Commons Attribution (CC BY 4.0) License
CC ---------------------------------------------------------------------------
DR AlphaFoldDB; P62569; -.
DR SMR; P62569; -.
DR GO; GO:0005576; C:extracellular region; IEA:UniProtKB-SubCell.
DR GO; GO:0042742; P:defense response to bacterium; IEA:UniProtKB-KW.
DR GO; GO:0051607; P:defense response to virus; IEA:UniProtKB-KW.
DR InterPro; IPR010000; Caerin_1.
DR Pfam; PF07440; Caerin_1; 1.
PE 1: Evidence at protein level;
KW Amidation; Amphibian defense peptide; Antibiotic; Antimicrobial;
KW Antiviral defense; Direct protein sequencing; Secreted.
FT PEPTIDE 1..25
FT /note="Caerin-1.1"
FT /id="PRO_0000010164"
FT PEPTIDE 1..16
FT /note="Caerin-1.1.5"
FT /id="PRO_0000010165"
FT PEPTIDE 1..15
FT /note="Caerin-1.1.6"
FT /id="PRO_0000010166"
FT PEPTIDE 1..12
FT /note="Caerin-1.1.7"
FT /id="PRO_0000010167"
FT PEPTIDE 1..10
FT /note="Caerin-1.1.8"
FT /id="PRO_0000010168"
FT PEPTIDE 3..25
FT /note="Caerin-1.1.1"
FT /id="PRO_0000010169"
FT PEPTIDE 13..25
FT /note="Caerin-1.1.3"
FT /id="PRO_0000010170"
FT MOD_RES 25
FT /note="Leucine amide"
FT /evidence="ECO:0000269|Ref.1"
SQ SEQUENCE 25 AA; 2585 MW; D8A5A460BB0EBE00 CRC64;
GLLSVLGSVA KHVLPHVVPV IAEHL